Mostrando 4 resultados de: 4
Filtros aplicados
Publisher
Drug Metabolism and Personalized Therapy(1)
OMICS A Journal of Integrative Biology(1)
Omics : a journal of integrative biology(1)
Pharmacogenomics(1)
Área temáticas
Medicina y salud(4)
Farmacología y terapéutica(3)
Bioquímica(1)
Grupos de personas(1)
Interacción social(1)
Origen
scopus(4)
CYP450 Genotype/Phenotype Concordance in Mexican Amerindian Indigenous Populations-Where to from Here for Global Precision Medicine?
ArticleAbstract: Global precision medicine demands characterization of drug metabolism and phenotype variation in divPalabras claves:Biomarkers, developing world omics, drug metabolism variation, global personalized medicine, Systems DiagnosticsAutores:Adrián LLerena, de Andrés F., Naranjo M.E.G., Ramos B., Sosa-Macías M.G.Fuentes:scopusPharmacogenetic research activity in Central America and the Caribbean: A systematic review
ReviewAbstract: Aim: The present review was aimed at analyzing the pharmacogenetic scientific activity in Central AmPalabras claves:Biomarkers, Caribbean Region, Central America, pharmacogenetics, PharmacogenomicsAutores:Adrián LLerena, Campos M.D.L.A., Céspedes-Garro C., Duconge J., Humberto Fariñas, Montané-Jaime L.K., Naranjo M.E.G., Penãs-Lledó E.M., Ramirez R., Roblejo H., Rodrigues-Soares F., Serrano V., Villagrán C.I.Fuentes:scopusPharmacogenetics in Central American healthy volunteers: Interethnic variability
ReviewAbstract: Ethnicity is one of the major factors involved in interindividual variability to drug response. ThisPalabras claves:Admixed, Afro-Caribbean, Amerindian, Biomarkers, Central America, CYP1A2, CYP2C19, CYP2D6, CYP2E1, G6PD, HLA, LDLR, MDR1, NAT2, pharmacogenetics, TP53Autores:Adrián LLerena, Barrantes R., Céspedes-Garro C., Humberto Fariñas, Naranjo M.E.G., Ramirez R., Serrano V.Fuentes:scopusLessons from Cuba for global precision medicine: CYP2D6 genotype is not a robust pbkp_redictor of CYP2D6 ultrarapid metabolism
ArticleAbstract: A long-standing question and dilemma in precision medicine is whether and to what extent genotypingPalabras claves:Biomarkers, developing world omics, Diagnostic Medicine, Innovation Systems, personalized medicine, system diagnosticsAutores:Adrián LLerena, Calzadilla L.R., de Andrés F., Dorado P., González I., Naranjo M.E.G., Penãs-Lledó E.M.Fuentes:scopus